- Home
- ELVA vs RCEL Comparison
ELVA vs RCEL Comparison
Compare ELVA & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVA
- RCEL
- Stock Information
- Founded
- ELVA 1996
- RCEL N/A
- Country
- ELVA Canada
- RCEL United States
- Employees
- ELVA N/A
- RCEL N/A
- Industry
- ELVA
- RCEL Medical/Dental Instruments
- Sector
- ELVA
- RCEL Health Care
- Exchange
- ELVA Nasdaq
- RCEL Nasdaq
- Market Cap
- ELVA 125.5M
- RCEL 114.3M
- IPO Year
- ELVA N/A
- RCEL N/A
- Fundamental
- Price
- ELVA $4.69
- RCEL $3.91
- Analyst Decision
- ELVA Strong Buy
- RCEL Buy
- Analyst Count
- ELVA 3
- RCEL 5
- Target Price
- ELVA $6.50
- RCEL $11.75
- AVG Volume (30 Days)
- ELVA 711.6K
- RCEL 196.9K
- Earning Date
- ELVA 12-10-2025
- RCEL 11-06-2025
- Dividend Yield
- ELVA N/A
- RCEL N/A
- EPS Growth
- ELVA 58.59
- RCEL N/A
- EPS
- ELVA 0.03
- RCEL N/A
- Revenue
- ELVA $54,875,000.00
- RCEL $72,401,000.00
- Revenue This Year
- ELVA $46.40
- RCEL $19.96
- Revenue Next Year
- ELVA $46.08
- RCEL $33.43
- P/E Ratio
- ELVA $171.66
- RCEL N/A
- Revenue Growth
- ELVA 10.88
- RCEL 20.59
- 52 Week Low
- ELVA $1.80
- RCEL $3.35
- 52 Week High
- ELVA $7.72
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- ELVA 37.55
- RCEL 47.62
- Support Level
- ELVA $4.10
- RCEL $3.64
- Resistance Level
- ELVA $4.78
- RCEL $4.09
- Average True Range (ATR)
- ELVA 0.30
- RCEL 0.25
- MACD
- ELVA -0.03
- RCEL 0.06
- Stochastic Oscillator
- ELVA 37.50
- RCEL 76.87
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.